Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Chagas Cardiomyopathy

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Chagas Cardiomyopathy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barcelos, LS; Ishii, S; Romanha, AJ; Santana, G; Shimizu, T; Silva, JS; Soares, MB; Talvani, A; Teixeira, MM1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Chagas Cardiomyopathy

ArticleYear
Experimental Trypanosoma cruzi infection in platelet-activating factor receptor-deficient mice.
    Microbes and infection, 2003, Volume: 5, Issue:9

    Topics: Animals; Antibodies, Protozoan; Cells, Cultured; Chagas Cardiomyopathy; Chemokine CCL2; Chemokine CCL5; Female; Heart; Immunoglobulin M; Interferon-gamma; Leukotriene B4; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Nitric Oxide; Parasitemia; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Trypanosoma cruzi; Tumor Necrosis Factor-alpha

2003